Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Halelujah!

<< Previous

Bullboard Posts

Next >>

Comment by BILLMINERon Oct 06, 2010 6:29pm

213 Views

Post# 17537674

RE: RE: Halelujah!

With near term revenue from Hudbay's production of Halo's Lost Deposit and the great potential of finding more deposits in the area, markets arequickly realizing how much Halo is undervalued. Probably one of the most undervalued juniors out there. A junior miners with proven resources of copper and gold with JV with a major(Hudbay).

Halo also has a JV with Goldcorp in Red lake with great upside potential. Still Halo has a market cap of only approx 9 million. Revenue from the Lost deposit should amount to approx 50 million alone. Only approx 23 million shares fully diluted. Hudbay will come out with results from metallurgical tests this month. Remember gold and silver credits were never included in pervious metallurgical tests.

just my opinion

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects